Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Meeting: Cancer Alliance Clinical Leadership Group Date: 4 May 2017 Time: 10.00am Venue: Evolve Business Centre Present: Name In attendance: Apologies: Rachel Bannister-Young, Lead Cancer Nurse, Sunderland Paul Barrett, Skin Chair, CDDFT Richard Bliss , Lead Clinician Newcastle Tony Branson, (Chair) Clinical Lead, Cancer Alliance Alison East, Macmillan Lead Cancer Nurse Newcastle Simon Endersby , Head and Neck Chair, Nuth Nicky Hand, South Tees representing Angela Wood Jan Harley Lead Cancer Nurse N Tees & Hartlepool Carolyn Harper, Cancer Manager Gateshead Kath Jones, Alliance Delivery Lead, Cancer Alliance Mark Katory Cancer Clinical Lead Gateshead Jo MacIntosh, Macmillan Engagement and co-design manager Adrienne Moffett, CA Delivery Manager Sheila Pearson Cancer Clinical Lead, North Cumbria Mel Robertson, Cancer Lead Clinician, Sunderland Jonathan Slade, GP Oliver Schulte , Cancer Lead Clinical, South Tyneside Jonathan Slade Alliance Clinical GP Lead Chris Walker, Radiology Chair Mark Weatherhead, Lead Clinician, Northumbria Linda Wintersgill, Information and Data Manager, CA Caron Woodward, Lead Cancer Nurse, CDDFT Pat Wright, GP Lead , North Durham CCG Claire McNeill Quality Surveillance Co-ordinator , Cancer Alliance Alison Featherstone, Manager, Cancer Alliance Jonathan Aning Urology Chair, Newcastle Chris Tasker, Network GP Cancer Lead, Cancer Alliance Robin Armstrong, Gail Jones, Haematology Chair, Newcastle John Painter, Upper GI Chair Angela Wood, Cancer Lead Clinical , South Tees Tony Sproston, Gynae Chair, Northumbria Ralph Jackson, Radiology Chair, Newcastle Ian Pedley, Newcastle Clare Scarlett North Tyneside CCG Henry Choi, GP, Sunderland Bill Hall, GP, South Tyneside Initials RBY PB RB TB AE SE NH JH CH KJ MK JM AM SP MR JS OS JS CW MW LW CW PW CM AF JA CT RA GJ JP AW TS RJ IP CS HC BH 1 MINUTES 1. INTRODUCTION Lead Enc 1.1 Welcome and Apologies TB welcomed all to the meeting, apologies as listed above. 1.2 Declaration of Conflict of Interest There were no declarations of conflict of interest. 1.3 Minutes from Previous meeting 07.3.17 Minutes agreed as a true and accurate record. Enc 1 1.4 Matters Arising Endocrine MT asked about the specific pathway for endocrine cancer pathways. Information requested but not yet received once this has been received information will be forwarded to the group. 2. AGENDA ITEMS UPDATES 2.1 Cancer Alliance Update Delivery Plans Delivery plan reviewed received and no additional comments Cancer Transformation Bids TB updated on the cancer transformation bids. Still awaiting official confirmation but understand we have been granted the whole account of the bid which is approx. £6million over two years. Localities have been asked to consider how they will utilise the two new posts in their region. Launch Event- Next Steps TB felt the Northern Cancer Alliance launch event went well. AM advised it is hoped to have another event next year to look at progress made with the workplan. 2.2 MDT Effectiveness 2 TB updated group on the work being undertaken on MDT effectiveness. Gap analysis is being undertaken and due to be completed by August 2017 with a meeting to review this analysis at a MDT review meeting which is due to be held Friday 15 September 2017. All providers to share benchmarking information at the September meeting. Alliance will develop a benchmarking tool to assist process and all to share good examples of proformas. MR advised the group she had not seen core member attendance in any of the current Quality Surveillance measures and queried if these had been removed already. 2.3 Upper GI Cancers AM updated on the joint work being undertaken with specialised commissioning and the cancer alliance. AM requested the group to endorse the tertiary referral form which has been approved by Upper GI Expert Advisory Group. AM will send out via email, if anyone has any objection please email [email protected] within two weeks or receiving email. If no objections received by 23 May document will be considered endorsed. AM MR asked if trusts could copy the form, with all relevant information, onto their own Trust forms, and would this be acceptable. This would assist the trust in having some data self-populated and reduce time taken to complete. TB confirmed if the data was in the same place this would be acceptable and would be more efficient for the trusts. 2.4 Regional Breast Services TB updated group on work being undertaken to review regional breast services. KJ advised an updated report would be sent via email for information. 2.5 Diagnostics Update report was circulated with the minutes. Unfortunately neither Katie Elliot nor Chris Tasker could 3 attend this meeting. 2.6 No smoking Event 26 April - Updates TB advised there was a presentation by Angus Bell at the Northern Cancer Alliance Launch event showing progress made in reducing smoking in the Mental Health Trust Regional Task force – Smoke free NHS held its first meeting on the 26 April and looking at a number of different pieces of work and how the cancer alliance could contribute to this. Next meeting is due to be held on the 12 July 2017. RC discussed the variation between trusts and obstacles such as who takes responsibility to police this. TB also discussed the impact of staff who smoke. 2.7 2ww referral forms Currently requesting feedback, via online survey, from both Primary and Secondary care to ensure the forms are appropriate and to make any appropriate changes if needed. Link provided to access the survey. All feedback needs to be completed by the end of May. SE queried head and neck 2ww referral form and the new National advice for a dental referral and asked if this was impacting on 2ww. KJ advised the Head and Neck Expert Advisory Group didn’t agree with this requirement and it’s not included within the alliance 2ww referral form. JS advised numbers were small and he agreed patients would not put any importance on the GPs advising them to refer to a dentist. 3. AGENDA ITEMS FOR DISCUSSION 3.1 Lung Pathways The Alliance is committed to reducing variation in services and improving outcomes regionally. To start this work an 4 event has been arranged due to be held on the 23 June at the Radisson Blu in Durham by invitation only. Trusts have been asked to provide 10 appropriate delegates for different specialities to look how to introduce this into practise and share best practise. KJ will be inviting primary care to the meeting via the cancer in the community distribution lists. . 3.2 KJ Performance Report LW advised data is sparse, now have 8 months of data and generally if patients are referred pathway is longer. Median transfer date across all sites is 33 days but there is variation between tumour sites. Lung median transfer date is above the nationally recommended 38 days. Work will continue to monitor allocations and transfer points at rumour and trust level. Work with EAGs to incorporate realistic transfer points into pathways and review data with the group. LW advised she is unsure when the new process will be introduced. Detailed report will be circulated via email. If anyone has comments of feedback on the report to email [email protected] 4. STANDING ITEMS 4.1 Any other Business Sentinel node biopsies. SE discussed NICE recommendations regarding Sentinel node biopsies. Discussed the difficulties to implement in other areas. PB advised if depends on the process chosen. This will impact on outcome of test for the patients. NICE recommendations state Sentinel node biopsies must be offered to patients. Head and Neck - National audit No reported data received. LW to investigate and update the group via email. LW 4.2 Next meeting Friday 29 September 2017, 2.00-4.00 Evolve Business Centre Tuesday 14 November 2017 10.00-12.00 (telecom) 5. MEETING CLOSE Contact [email protected] tel 01138252976 5